non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Inclusion criteria of patients with non-small cell lung cancer: (1) Participants who are dignosed as stage I or IV non-small cell lung cancer by pathological or cytological methods; (2) Aged 30~80; (3) ECOG score: 0-3, KPS=50; (4) Participants have signed informed consent and have good compliance. 2. Inclusion criteria of non-cancer controls: (1) Participants who are not diagnosed as cancer; (2) Aged 30~80 years; (3) Participants have signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Exclusion criteria of patients with non-small cell lung cancer: (1) Participants who have received immunoenhancer or immunosuppressant half a month before sampling; (2) Participants who have received radiotherapy and chemotherapy half a month before sampling; (3) Participants who are diagnosed as severe recurrent diseases (such as autoimmune diseases and leukemia); (4) Participants who are diagnosed as microbial (including bacterial, viral and mycoplasma infection) infection; (5) Participants who have received blood transfusion one year before sampling. 2. Exclusion criteria of non-cancer controls: (1) Participants who are diagnosed as severe recurrent diseases (such as autoimmune diseases and leukemia); (2) Participants who are diagnosed as microbial (including bacterial, viral and mycoplasma infection) infection; (3) Participants who received blood transfusion one year before sampling.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| APTT/PT/TT/FIB;C4a level in plasma; | — |
Countries
China
Contacts
Shanghai University of Traditional Chinese Medicine